Pramod Sachdeva

Pramod Sachdeva is the Founder and Managing Director at Princeton Blue. Pramod has been helping Life Sciences organizations for 16 years with Low-code process automation solutions to modernize Clinical, Regulatory, Lab and Drug Safety processes. With over 35 years of business and technology consulting experience, Pramod brings tremendous knowledge to help Life Sciences clients navigate their process automation journey using Low-code technology. The ultimate goal is to unify the enterprise data view with standardized business processes and rules to provide an efficient and transparent way to get work done.

Solving Clinical Supply Chain Challenges with Process Automation Feature

Solving Clinical Supply Chain Challenges with Process Automation

By

Picture this: A critical clinical trial is weeks from a milestone when temperature-sensitive investigational drugs sit in Singapore customs for three days. Meanwhile, a site coordinator in Boston can’t locate their latest shipment, and your team has just spent two hours manually reconciling inventory across five different spreadsheets. These scenarios aren’t rare. They’re the everyday […]

Solving Clinical Supply Chain Challenges with Process Automation Read more

Agentic AI in Study Start-Up: Automating Documents, Approvals, and Site Activation Blog Feature

Agentic AI in Study Start-Up: Automating Documents, Approvals, and Site Activation

By

What is Study Start-Up in Clinical Trials? Study Start-Up (SSU) is the phase in clinical trials where everything is prepared before a site can begin enrolling patients. It includes activities such as finalizing essential study documents, completing regulatory and ethics approvals, collecting required site information, and activating sites for trial execution. In simple terms, Study

Agentic AI in Study Start-Up: Automating Documents, Approvals, and Site Activation Read more

How Modern Teams Ace Regulatory Submissions From Fragmentation to Flow Blog Feature 2

How Modern Teams Ace Regulatory Submissions: From Fragmentation to Flow

By

If you work in pharma or biotech, you know that accurate, complete, and well-coordinated regulatory submissions are critical to keeping development timelines on track. Every filing — whether it’s a new drug application, a variation, or a label update — passes through multiple hands across clinical, CMC, safety, and regulatory teams. And while the science

How Modern Teams Ace Regulatory Submissions: From Fragmentation to Flow Read more

How Process Automation and AI Minimize Human Error in the Drug Development Lifecycle Blog Feature

How Process Automation and AI Minimize Human Error in the Drug Development Lifecycle

By

Picture this: A global medical device manufacturer misses a small but crucial update to its product labeling in Europe. The result? A product recall, millions lost, and significant damage to trust. Or consider a pharma company where a single error in batch release documentation delays a life-saving drug’s approval. These are not rare occurrences. They

How Process Automation and AI Minimize Human Error in the Drug Development Lifecycle Read more

AI in Life Sciences Transforming Clinical and Regulatory Workflows Blog Feature

AI in Life Sciences: Transforming Clinical and Regulatory Workflows

By

Pharma and biotech leaders today are under immense pressure. You’re asked to accelerate trial timelines, cut costs, and stay compliant with constantly evolving regulations; all while bringing innovative therapies to market faster. Manual processes and siloed systems make these goals harder to achieve. That’s where Artificial Intelligence (AI) is changing the game. AI is no

AI in Life Sciences: Transforming Clinical and Regulatory Workflows Read more

Shortcast 9 Smarter Site Selection with Process Automation Feature

Shortcast Episode 9: Smarter Site Selection with Process Automation

By

Selecting the right sites is one of the most critical and challenging steps in clinical trials. Yet, many sponsor organizations still rely on outdated processes, siloed data, and manual workflows that slow everything down and increase risk. In this shortcast, Pramod Sachdeva, Founder and Managing Director of Princeton Blue, explores how process automation is helping

Shortcast Episode 9: Smarter Site Selection with Process Automation Read more

Shortcast 8 How are leading pharma companies modernizing their labs Feature

Shortcast Episode 8: How are leading pharma companies modernizing their labs?

By

Pharma labs are under constant pressure to do more—faster. But with rising sample volumes, complex experiments, and rigid Laboratory Information Management Systems (LIMS), many labs are struggling to keep pace. While LIMS have served as the backbone of lab operations for years, they often create bottlenecks with their rigid workflows and siloed data. Labs are

Shortcast Episode 8: How are leading pharma companies modernizing their labs? Read more

Shortcast 7 Simplifying Global Label Management Feature

Shortcast Episode 7: Simplifying Global Label Management

By

How do global pharma companies ensure every product label remains accurate, compliant, and up to date across dozens of markets? Behind the scenes, label management is one of the most complex operational challenges in the pharmaceutical industry. Each country has its own regulatory authorities, workflows, and submission requirements, creating a maze of processes that can

Shortcast Episode 7: Simplifying Global Label Management Read more

Bridging the Legacy Gap How Data Fabric Powers Life Sciences Integration Blog Feature

Bridging the Legacy Gap: How Data Fabric Powers Life Sciences Integration

By

Key Topics Covered: The Legacy System Dilemma in Life Sciences What is Data Fabric? And Why It Matters? Life Sciences Use Cases for Data Fabric Benefits of Data Fabric in Life Sciences The Role of an Expert Partner Case Example: Faster Trial Reporting Through Unified Data Access Future Trends: AI-Enhanced and Cloud-Native Data Fabrics Data

Bridging the Legacy Gap: How Data Fabric Powers Life Sciences Integration Read more

Shortcast 6 What is Low code Process Automation Feature

Shortcast Episode 6: What is Low-code Process Automation?

By

As the pace of drug discovery accelerates, the organizations that thrive will be those that can adapt quickly. Traditional, siloed systems often make it difficult to respond to changing market conditions or evolving regulatory requirements. That’s why Low-code Process Automation is gaining momentum across the life sciences industry. In this shortcast, Pramod Sachdeva, Founder &

Shortcast Episode 6: What is Low-code Process Automation? Read more

Scroll to Top